Reading Time: 4 minutesEach year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on the eyes – in most people
Search Results for: clinical trial
Reading Time: 2 minutesOn Friday 5 May in America, the FDA, the organisation that approves drugs, announced that they’d granted a licence for the drug known as a
Reading Time: 4 minutesAs well as all the networking, debate and new information being shared, the International Symposium on ALS/MND is also a time to celebrate achievements by
Reading Time: 4 minutesBrain banks are a vital resource in MND research. The MRC London Neurodegenerative Diseases Brain Bank was established in 1989. It is part of King’s College
Reading Time: 2 minutesToday we announce a new collaboration for a preclinical research study on the diabetes drug liraglutide, in the hope that positive results will lead to
Reading Time: 2 minutesThere is a critical need to find a biomarker for MND to speed up diagnosis, monitor disease progression and improve clinical trials. A biomarker is
Reading Time: 4 minutesDuring MND Awareness Month we are highlighting some of the research the MND Association funds in our ‘Project a Day’ series. Today, on global ALS/MND
Reading Time: 2 minutesBiomarkers in Oxford (BioMOx) is a research project with the aim of identifying a diagnostic biomarker for MND, which could be used to track the
Reading Time: 2 minutesDeposits of the protein TDP-43 are found within the motor neurones in the majority of cases of MND, and are considered a pathological hallmark of